The Latest in Multiple Sclerosis

Clinical Neurology News

T-cell biomarker not viable for detecting PML risk with natalizumab

January 5, 2016

Multiple Sclerosis

Neurology Reviews

Neuromyelitis Optica Spectrum Disorder Presents Diagnostic and Treatment Challenges

December 29, 2015

Multiple Sclerosis

Neurology Reviews

Amiselimod May Provide Benefits for Patients With Relapsing-Remitting MS

December 29, 2015

Multiple Sclerosis

Neurology Reviews

Radiologically Isolated Disease Is Part of the MS Spectrum

December 28, 2015

Multiple Sclerosis

Clinical Neurology News

Evidence points to early brain cell death as catalyst for MS inflammation, demyelination

December 14, 2015

Multiple Sclerosis

Neurology Reviews

Polyunsaturated Fatty Acids May Reduce Risk of MS

December 2, 2015

Multiple Sclerosis

Neurology Reviews

Extended Dosing Improves Safety of Natalizumab in MS Treatment

December 1, 2015

Multiple Sclerosis

Clinical Neurology News

Study suggests radiologically isolated disease is part of MS spectrum

December 1, 2015

Multiple Sclerosis

Neurology Reviews

NEDA-4 May Predict MS Outcomes Better Than NEDA-3

December 1, 2015

Multiple Sclerosis

Neurology Reviews

Relapses and MRI Activity Predict MS Treatment Response

December 1, 2015

Multiple Sclerosis

Neurology Reviews

Researchers Investigate New Myelin-Repair Strategies

November 30, 2015

Multiple Sclerosis

Neurology Reviews

Which MS Biomarkers Predict Disease Progression?

November 30, 2015

Multiple Sclerosis

Clinical Neurology News

Pseudoatrophy with interferon beta-1a may warrant MRI delay in MS patients

November 17, 2015

Multiple Sclerosis

Neurology Reviews

Exclusive Breastfeeding May Mitigate Postpartum MS Relapses

November 4, 2015

Multiple Sclerosis

Clinical Neurology News

Burden of psychiatric comorbidity higher in MS patients

November 3, 2015

Multiple Sclerosis